Doppel
Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.
News & Highlights
New chapter for Doppel
Milan, 23rd July 2024 An agreement was signed today between the international investment fund Trilantic Europe and the Italian investment fund Alto Capital IV, managed by Alto Partners SGR, to [...]
Nasce DMX PHARMA
Milano, 23 Luglio 2024 In data odierna è stato siglato un accordo tra il fondo di investimento internazionale Trilantic Europe e il fondo di investimento Italiano Alto Capital IV, gestito [...]
Doppel Farmaceutici proudly celebrates its thirtieth anniversary!
Founded in 1994 as a spin-off of the Hoechst Roussel Group, Doppel Farmaceutici has grown to become one of the leading European CDMOs. What began with just over 40 employees [...]
Environmental KPI
OVERALL SCORE
ENVIRONMENT
LABOR & HUMAN RIGHTS
ETHICS
SUSTAINABLE PROCUREMENT
Corporate history highlights
The company is committed to applying its innovative technologies, deep knowledge and broad experience to develop products of the highest quality for its customers worldwide.
Doppel has a strong track record in building and forging close partnerships with its customers. The company works very closely with its partners to provide high quality services tailored to the specific needs of each individual customer at all stages from formulation, development and manufacturing all the way to marketing and post-marketing controls.
In particular, Doppel provides a specialist consultative service to customers prior to each project in order to determine together the most effective and bespoke solution for the product.